Polyphophazenes as anti-cancer drug carriers: From synthesis to application

被引:33
|
作者
Akram, Muhammad [1 ]
Wang, Li [1 ]
Yu, Haojie [1 ]
Amer, Wael A. [1 ]
Khalid, Hamad [1 ]
Abbasi, Nasir M. [1 ]
Chen, Yongsheng [1 ]
Saleem, Zain-ul-Abdin M. [1 ]
Tong, Rongbai [1 ]
机构
[1] Zhejiang Univ, Dept Chem & Biol Engn, State Key Lab Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Anti-cancer drug; Poly(organophosphazene); pH-responsiveness; Drug delivery system; LIVING CATIONIC-POLYMERIZATION; HIGH-MOLECULAR-WEIGHT; AMBIENT-TEMPERATURE POLYMERIZATION; RECENT RESEARCH PROGRESS; IN-VITRO CYTOTOXICITY; CONTROLLED-RELEASE; AMPHIPHILIC POLYPHOSPHAZENES; PHOSPHONITRILIC COMPOUNDS; MULTIDRUG-RESISTANCE; CLINICAL-EXPERIENCE;
D O I
10.1016/j.progpolymsci.2014.07.009
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Currently, most of administered anti-cancer drugs are low molecular weight compounds (as compare to polymers) and hydrophobic in nature. Such small molecular anti-cancer drugs possess fast clearance rate from the blood circulating system and have toxic side effects. Poly(organophosphazenes) have wide range of biomedical applications owing good biocompatibility, sustainability and degradability into non-toxic by-products. So, in this review, we have carefully selected such poly(organophosphazenes), which proved to be good anti-cancer drug carriers because of overcoming crucial issues related to the administration of anti-cancer drugs i.e. poor hydrophilicity, lack of cancer cells specificity, and fast clearance rate from blood circulating system. Thence, the main focus of this review is to highlight the advancement that have been achieved in the synthesis of poly(organophosphazenes) and their application in anti-cancer drug delivery system (DDS). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1987 / 2009
页数:23
相关论文
共 50 条
  • [31] CISPLATIN - NEW ANTI-CANCER DRUG
    ROZENCWEIG, M
    ABELE, R
    BEDOGNI, P
    KENIS, Y
    LOUVAIN MEDICAL, 1979, 98 (10): : 679 - 684
  • [32] Mitosis as an anti-cancer drug target
    Salmela, Anna-Leena
    Kallio, Marko J.
    CHROMOSOMA, 2013, 122 (05) : 431 - 449
  • [33] The meaning of lipid carriers for fucoxanthin anti-cancer properties
    Tokarek, Wiktor
    Pisarek, Aleksandra
    Listwan, Stanislaw
    Kocemba, Monika
    Lesniak, Piotr
    Pilch, Magdalena
    Pagacz, Joanna
    Leonowicz, Gracjana
    Stalinska, Krystyna
    Latowski, Dariusz
    NEW BIOTECHNOLOGY, 2016, 33 : S75 - S75
  • [34] PASSIVE AND ACTIVE TUMOR TARGETING OF NANO CARRIERS FOR ANTI-CANCER DRUG DELIVERY- A REVIEW
    Manhas, Daljeet Singh
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 3 (11): : 1345 - 1349
  • [35] Thymoquinone: A promising anti-cancer drug from natural sources
    Gali-Muhtasib, Hala
    Roessner, Albert
    Schneider-Stock, Regine
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (08): : 1249 - 1253
  • [36] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shoyo Shibata
    Maiko Matsushita
    Yoshimasa Saito
    Takeshi Suzuki
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 442 - 448
  • [37] Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan
    Shibata, Shoyo
    Matsushita, Maiko
    Saito, Yoshimasa
    Suzuki, Takeshi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (04) : 442 - 448
  • [38] RAS GTPase AS THE DRUG TARGET FOR ANTI-CANCER DESIGNING OF DRUG FROM TEMPLATE
    Krishnapriya, A. S.
    Namboori, P. K. Krishnan
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (11): : 4457 - 4461
  • [39] Small-Molecule Anti-Cancer Drugs From 2016 to 2020: Synthesis and Clinical Application
    Wang, Lijiao
    Li, Rong
    Song, Chen
    Chen, Yanli
    Long, Haiyue
    Yang, Lingling
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (09)
  • [40] Silver graphene quantum dots as drug delivery platforms for anti-cancer application
    Villanueva, Rafael A.
    Cole, Tori
    Medina, Nataniel
    Morell, Gerardo
    Weiner, Brad
    CANCER RESEARCH, 2024, 84 (06)